MBQ Pharma
Pharmaceuticals - San Juan, San Juan, Puerto Rico
MBQ Pharma Employees
MBQ Pharma Details
MBQ-Pharma targets Rac and CDC42 as key targets for tumor growth inhibition and removal of pre-existing metastasis. MBQ-167 is a first-in-class nanomolar IC50 inhibitor for Rac and CDC42 and has been shown in mouse tumor models to inhibit tumor growth and to reverse advanced metastasis. MBQ-167 has also been shown to have no toxicity findings in rats and dogs through GLP studies and in Safety Pharmacology studies. The IND for MBQ-167 is scheduled by the end of 2021.
Website:
http://www.mbqpharma.com
Employees:
4
HQ:
Location:
San Juan, San Juan, Puerto Rico
Revenue:
MBQ Pharma Technologies
Email Providers
Gmail
Load Balancers
Apache
CMS
WordPress.org
Hosting
Blue Host
Other
Google Apps
Online Video Platforms
YouTube